Pac Premier
Giving Guide
You are here:  Home  >  Biotech  >  Current Article

Arcutis shares soar after $160 million IPO

By   /   Monday, February 3rd, 2020  /   Comments Off on Arcutis shares soar after $160 million IPO

    Print       Email
Shares of the Tri-Counties’ newest public company, Arcutis Biotherapeutics, surged 15 percent in the first day of trading after its public debut, following a larger-than-expected IPO that raised nearly $160 million. The Westlake Village biotech company sold some 9.4 million shares of stock, slightly more than it outlined in its registration statement, at $17 each,…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Limoneira, Calavo both report earnings growth as produce industry continues recovery

Read More →